PRESS RELEASE published on 03/19/2026 at 18:30, 1 month 18 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
BRIEF published on 03/18/2026 at 18:05, 1 month 19 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities Transparence Financière Pharmaceutique Atlas Special Opportunities Investissements Digitaux Oxurion
BRIEF published on 03/18/2026 at 18:05, 1 month 19 days ago Oxurion Acknowledges Transparency Notification from Atlas Pharmaceuticals Transparency Oxurion Belgian Legislation Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 1 month 19 days ago Oxurion accuse réception de la notification de transparence d'Atlas Transparence Médicaments Oxurion Législation Belge Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 1 month 19 days ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
PRESS RELEASE published on 03/18/2026 at 18:00, 1 month 19 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgeving met betrekking tot aandelenbezit en kondigt ambitie aan om Europese farmaceutische onderaannemers te verwerven Transparantiekennisgeving Euronext Brussel Oxurion NV België Farmaceutische Onderaannemers
PRESS RELEASE published on 03/18/2026 at 18:00, 1 month 19 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a stake increase above the threshold. Oxurion specializes in acquiring pharmaceutical subcontractors Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Pharmaceutical Subcontractors
BRIEF published on 03/16/2026 at 18:05, 1 month 21 days ago Oxurion expands its capital following the conversion of bonds Ordinary Shares Convertible Bonds Capital Increase Atlas Oxurion
BRIEF published on 03/16/2026 at 18:05, 1 month 21 days ago Oxurion élargit son capital suite à la conversion d'obligations Obligations Convertibles Atlas Actions Ordinaires Oxurion Augmentation Capital
BRIEF published on 03/16/2026 at 18:05, 1 month 21 days ago Oxurion Increases Voting Shares Following Conversion Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
Published on 05/07/2026 at 05:40, 3 hours 12 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 6 hours 52 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 9 hours 22 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 47 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 9 hours 52 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 08:48, 4 minutes ago Finnvera’s Annual General Meeting: New members to Finnvera’s Board of Directors and Supervisory Board
Published on 05/07/2026 at 08:36, 16 minutes ago Cherry SE publishes results for the first quarter of 2026 – Operating profitability significantly improved
Published on 05/07/2026 at 08:30, 22 minutes ago L'UE mise sur une politique climatique axée sur le marché: allègement des péages et des normes CO₂ pour les poids lourds
Published on 05/07/2026 at 07:43, 1 hour 9 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 14 hours 52 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 14 hours 52 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 14 hours 52 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
